Clinical Trial Update: A Phase I- Sequential Cohort Dosing to Determine Maximum Tolerated Dose in Healthy Male Volunteers. [Phase 1]

View source ↗

Summary

Phase I sequential-cohort study in healthy male volunteers to determine the maximum tolerated dose; results were posted in 2017. Sponsor: Newron Pharmaceuticals…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Newron Pharmaceuticals SPA | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED | Results posted: 2017-06-20